HOME >> BIOLOGY >> NEWS
Past AACR president Susan B. Horwitz elected to National Academy of Sciences

PHILADELPHIA Susan Band Horwitz, Ph.D., president of the American Association for Cancer Research in 2002-2003, was elected to the National Academy of Sciences last week.

Dr. Horwitz holds the Rose C. Falkenstein Chair in Cancer Research at Albert Einstein College of Medicine of Yeshiva University, Bronx, N.Y., where she also serves the Albert Einstein Comprehensive Cancer Center as Associate Director for Drug Development.

She is one of 72 new members elected to the Academy at its 142nd annual meeting in Washington, D.C. Six other AACR members also were among those selected.

The research program in Dr. Horwitz's laboratory focuses on the development of drugs derived from natural products for the treatment of malignancies, and the problem of drug resistance. It was there that the novel structure and unique mechanism of action of the widely used anti-cancer drug Taxol were first described. Taxol, isolated from the yew tree, works at the molecular level to arrest cell growth and induce cell death. Dr. Horwitz's research led to its development and approval as a treatment for ovarian, breast and lung cancers.

Currently, Dr. Horwitz is investigating newly discovered, potentially important antitumor drugs, such as the epothilones and discodermolide, which have a mechanism of action similar to that of Taxol; and she is evaluating new drug combinations. Her findings suggest that Taxol combined with signal transduction inhibitors may be more effective compared to single agents.

Dr. Horwitz also has developed taxol-resistant cell lines derived from mammalian tumor cells growing in tissue culture, to serve as a model system for studying drug resistance. She is working on quantitative mass spectrometric-based methods to pursue further the evidence in human cancer cell lines, tissues and tumors that different antigenic markers have different sensitivities to Taxol, and may also be related to drug resistance.

"Dr. Horwitz is co
'"/>

Contact: Elizabeth Tait
tait@aacr.org
215-440-9300
American Association for Cancer Research
10-May-2005


Page: 1 2

Related biology news :

1. Cold Spring Harbor Laoratory president wins Curtin Medal
2. Could USA presidential DNA trail reveal Middle-Eastern origins?
3. Philippines president enacts new national conservation policy
4. University presidents: NY must act on stem cell research
5. Two Childrens Hospital Boston researchers win top presidential awards
6. Einsteins Susan Band Horwitz, PhD wins Bristol-Myers Squibb Cancer Research Award
7. Columbia University awards 2006 Horwitz Prize to biologist who explained gene transcription
8. Columbia University awards 2005 Horwitz Prize to Israeli structural biologist
9. Horwitz Prize to be shared by Tony Hunter, Anthony Pawson
10. Candidate research sites selected for the National Ecological Observatory Network
11. Depiction of findings selected as 2007 Image of the Year by Society for Nuclear Medicine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 25, 2020 , ... Mitotech ... partnership with Essex Bio-Technology, a bio-pharmaceutical company specializing in Ophthalmology and Dermatology, ... of SkQ1 ophthalmic solution in patients with moderate to severe Dry Eye ...
(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage ... Food and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) ... severe COVID-19. Approval of this IND allows Sentien to initiate a Phase 1/2 ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... Princeton, NJ, have entered into license agreements with Housey Pharma’s HMI subsidiary to ... Roche and J&J have annual Research and Development spending in excess of US ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., ... hiring of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. ... Sentien’s lead product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , a leading ... despite many obstacles created as a result of COVID-19. As a provider at ... medical practices and medical manufacturers by expanding access to device offerings, technology services, ...
(Date:6/28/2020)... ... June 25, 2020 , ... The Indoor Lab, a leading provider of sensor ... of all types to ensure cleanliness, distancing and occupancy with its patent pending WipeAway™ ... enabled business will provide a health performance index system that scores all aspects of ...
(Date:6/28/2020)... ... June 26, 2020 , ... ... security solutions providers, today announced its strong opposition to the recently introduced bicameral ... impose a blanket ban on most federal use of nearly all biometric and ...
Breaking Biology Technology:
Cached News: